Overview

A Multi-Center Study on the Metoprolol Optimal Dosing Pathway of Metoprolol Application in Chinese Patients With Acute Coronary Syndrome

Status:
Unknown status

Trial end date:
2020-07-30

Target enrollment:

Participant gender:

Summary

This study is to test the feasibility and tolerability of the metoprolol optimal dosing pathway by observing the percentage of patients achieving target dose followed the pathway on ACS patients during hospitalization.

Phase:

N/A

Details

Lead Sponsor:

Yun Dai Chen

Treatments:

Metoprolol